Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Esinil-25 Tablet

Esinil-25 Tablet

NAFDAC Reg. No. B4-5347 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 1 November 2026 · synced automatically from official sources.
Producto
Esinil-25 Tablet
Número NAFDAC
B4-5347
Principio activo
Hydrochlorothiazide
Dosis
25 mg
Forma
Tablet
Tamaño del envase
10 x 10's, 1 x 1000's
Fabricante
No Constan
Solicitante (titular)
Transglobe Pharmaceutical Company Limited
Approved
31 Jan 2024
Estado
Activo Ver en NAFDAC ↗
Registro válido hasta
30 Jan 2029
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Hydrochlorothiazide: uses, dosage and brands worldwide

Lo que encontramos

  • Esinil-25 Tablet is on the NAFDAC register with an active registration (B4-5347). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Esinil-25 Tablet

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. …

Cómo tomarlo y con qué frecuencia
  • Therapy should be individualized according to patient response
  • Use the smallest dosage necessary to achieve the required response
  • Adults For Edema - The usual adult dosage is 25 to 100 mg daily as a single or divided dose
  • Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week
  • With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur
  • For Control Of Hypertension - The usual initial dose
  • In adults is 25 mg daily given as a single dose
  • The dose may be increased to 50 mg daily, given as a single or two divided doses
  • Doses above 50 mg are often associated with marked reductions in serum potassium (see also PRECAUTIONS )
  • Patients usually do not require doses in excess of 50 mg of hydrochlorothiazide daily when used concomitantly with other antihypertensive agents
  • Infants and Children For Diuresis and For Control of Hypertension - The usual pediatric dosage is 0.5 to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age
  • In infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required (see PRECAUTIONS , Pediatric Use )
Infancia
  • There are no well-controlled clinical trials
  • In pediatric patients
  • Information on dosing in this age group is supported by evidence from empiric use
  • In pediatric patients and published literature regarding the treatment of hypertension in such patients. (See DOSAGE AND ADMINISTRATION , I nfants and Children )
While you are taking it

Non-melanoma Skin Cancer: Instruct patients taking hydrochlorothiazide to protect skin from the sun and undergo regular skin cancer screening.

Talk to a doctor first if
  • Anuria
  • Hypersensitivity to this product or to other sulfonamide-derived drugs
Medicines it may not mix with

When given concurrently the following drugs may interact with thiazide diuretics. Alcohol, Barbiturates, or Narcotics Potentiation of orthostatic hypotension may occur. Antidiabetic Drugs - (Oral Agents and Insulin) Dosage adjustment of the antidiabetic drug may be required. Other Antihypertensive Drugs Additive effect or potentiation. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively. …

Warnings

Use with caution in severe renal disease. In patients with renal disease, thiazides may precipitate azotemia. Cumulative effects of the drug may develop in patients with impaired renal function. Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma. Thiazides may add to or potentiate the action of other antihypertensive drugs. Sensitivity reactions may occur in patients with or without a history of allergy or bronchial asthma. The possibility of exacerbation or activation of systemic lupus erythematosus has been reported. …

Posibles efectos secundarios

The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity. Body As A Whole: Weakness. Cardiovascular: Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs). Digestive: Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea, anorexia. Hematologic: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia. …

Pregnancy and breastfeeding

Pregnancy Teratogenic Effects: Studies in which hydrochlorothiazide was orally administered to pregnant mice and rats during their respective periods of major organogenesis at doses up to 3,000 and 1,000 mg hydrochlorothiazide/kg, respectively, provided no evidence of harm to the fetus. There are, however, no adequate and well-controlled studies in pregnant women. …

If you take too much

The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. In the event of overdosage, symptomatic and supportive measures should be employed. Emesis should be induced or gastric lavage performed. Correct dehydration, electrolyte imbalance, hepatic coma and hypotension by established procedures. If required, give oxygen or artificial respiration for respiratory impairment. …

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-12-25.

Label for hydrochlorothiazide, the active ingredient registered with NAFDAC.

Check your pack of Esinil-25 Tablet

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Esinil-25 Tablet

What is in Esinil-25 Tablet?

Esinil-25 Tablet contains Hydrochlorothiazide (25 mg), as tablet, according to its NAFDAC registration record.

Is Esinil-25 Tablet registered with NAFDAC?

Yes. Esinil-25 Tablet is listed on the NAFDAC register under registration number B4-5347, and its registration is active as of 1 November 2026.

Has Esinil-25 Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Esinil-25 Tablet in our automatically synced alert list.

How can I check that my pack of Esinil-25 Tablet is genuine?

Run a free authenticity scan with the NAFDAC number B4-5347, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Esinil-25 Tablet?

Follow your prescription or the leaflet in your pack. The official label says: Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Adults For Edema - The usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent s…

What is Esinil-25 Tablet used for?

Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in t (Summarised from the official U.S. FDA label for hydrochlorothiazide. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Esinil-25 Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.